98%
921
2 minutes
20
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1136/gutjnl-2024-333437 | DOI Listing |
Dig Liver Dis
August 2025
Department of Gastroenterology, Portuguese Institute of Oncology of Porto, Porto, Portugal; Precancerous Lesions and Early Cancer Management Group, Research Center of IPO Porto (CI-IPOP)/CI-IPOP@RISE (Health Research Group), Portuguese Institute of Oncology of Porto (IPO Porto)/Porto Comprehensive C
Introduction: Patients with gastric atrophy (GA) and intestinal metaplasia (GIM) are considered to be at risk for gastric neoplasia (GN: dysplasia or cancer). During the last decades, standards of practice and endoscopic technologies have been developed and proposed. This meta-analysis reassesses GN incidence rates in GA and GIM patients, analyzing its evolution and the impact of standard protocols and scores.
View Article and Find Full Text PDFGut
January 2025
Department of Gastroenterology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China
World J Gastroenterol
January 2023
Department of Gastroenterology and Hepatology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Frontline Gastroenterol
January 2018
Department of Gastroenterology, Royal Hallamshire Hospital, Sheffield Teaching Hospitals, Sheffield, UK.
Objective: To evaluate the diagnostic yield of investigating dyspepsia with oesophagogastroduodenoscopy (OGD) with or without mucosal biopsy.
Design: Retrospective service evaluation study.
Setting: Two teaching hospitals: The Royal Hallamshire Hospital and Northern General Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, UK.